Philips says it has completed actionable registrations across sleep therapy and ventilator devices and is closing the U.S. Patient Portal related to its recall as of Jan. 1, 2026.

Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...

This article originally appeared in ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox. For ...

Sept 8 (Reuters) - Paris prosecutors opened a criminal probe into Philips (PHG.AS), opens new tab in June over its recall of sleep apnea devices, probing possible charges including aggravated fraud ...

Technology company Philips plans to cut an estimated 5% of its workforce, about 4,000 positions, due to losses caused by the recall of a sleep apnea product as well as supply chain issues, according ...

ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre screening, widening its reach before patients ever enter a sleep lab. Recent FDA approvals are supporting ResMed's role ...

Medical device manufacturer Philips announced the company will expand on a previous recall in an ongoing effort to remove equipment that could have a contaminant in one of the plastic components.

Eight deaths and 13 injuries have been associated with a class I recall of Philips Respironics’ BiPAP ventilators. FDA noted that the devices may unexpectedly reboot or enter an interoperative state.